Home > > Pharmaceuticals and Healthcare > > Bronchoscope Market Size, Share, Growth, Demand | Analysis Report - 2032
Bronchoscope Market - Size, Share, Industry Trends, and Forecasts (2025-2032)
ID : CBI_2302 | Updated on : | Author : Yogesh K | Category : Pharmaceuticals and Healthcare
Bronchoscope Market Scope & Overview:
Bronchoscope is a special type of medical instrument used for the lung. It examines the airways and lungs for the diagnosis and therapeutic purpose. It is a thin tube with light and camera attached to it. The instrument is inserted through the nose or the mouth. It enters the trachea and from there it is moved to into the smaller airways present in the lungs. Two main types of this instrument consist of flexible and rigid. The flexible types are used widely as they are easily moved into small airways.
Rigid types are used for procedures that require large channels for working. The application of this instrument includes diagnosis of conditions such as lung cancer, pneumonia, chronic obstructive pulmonary disease (COPD), tuberculosis (TB), and others. The use of this instrument in treatment includes foreign body removal, stent placement, ballon dilation, tumor removal, and others. The end-user consists of hospitals & clinics, ambulatory surgical centers, diagnostic centers, and others.
Bronchoscope Market Size:
Bronchoscope Market size is growing with a CAGR of 7.5% during the forecast period (2025-2032), and the market is projected to be valued at USD 2,756.28 Million by 2032 from USD 1,549.02 Million in 2024. Additionally, the market value for the 2025 attributes to USD 1,659.92 Million.
Bronchoscope Market Dynamics - (DRO) :
Key Drivers:
High Prevalence of Chronic Obstructive Pulmonary Disease is Driving the Bronchoscope Market.
Chronic Obstructive Pulmonary Disease (COPD) is a common lung disease that restricts the airflow. It includes breathing problems caused by emphysema or chronic bronchitis. The most cause of COPD includes occupational exposure to dust, fumes or chemicals, tobacco exposure from active smoking or passive exposure to second-hand smoke. These factors lead to the prevalence of COPD and the use of bronchoscopes for frequent diagnostic and therapeutic interventions.
For instance,
- The data published by World Health Organization, in November 2024, states that tobacco smoking accounts for over 70% of COPD cases in high income countries. In low- and middle-income countries tobacco smoking accounts for 30–40% of COPD cases, and household air pollution is a major risk factor.
Thus, the high prevalence of COPD because of tobacco smoking and other factors is driving the bronchoscope market expansion.
Development of Disposable Bronchoscopes is Propelling the Market.
Traditional reusable bronchoscopes generally require thorough cleaning and sterilization between procedures. This increases the risk of cross-contamination and hospitals acquire infections (HAIs). The development of novel disposable bronchoscopes eliminates these risks. They are beneficial to use if intensive care units and emergency rooms among others. The novel single-use instrument provides enhanced suction ability, improved image quality, and better maneuverability than the traditional models.
For instance,
- In April 2021, Olympus introducedH-SteriScope which is a single use bronchoscope line for advanced diagnostic and therapeutic procedures. This disposable novel model enhances the workflow and productivity of the procedures.
Thus, the development of novel instruments for diagnostic and therapeutic procedures for lungs in propelling the bronchoscope market expansion.
Key Restraints:
Stringent Regulatory Standards is Hampering the Bronchoscope Market Growth.
Stringent regulatory standards are imposed by government bodies worldwide. This causes constraints to the market. These regulations are designed to protect the environment and public health. It increases production costs and slow down the development of novel products. The bronchoscope instruments require approval from regulatory authorities for the commercialization and development of the instruments that are useful for diagnosis and therapeutic procedures for lungs.
Compliance with these regulations increases the cost of product development and testing. These instruments require extensive approval time. This delays and prevents the introduction of new instruments. Thus, as per the bronchoscope market analysis, the adherence to stringent regulatory standards hinders the growth of the market globally.
Future Opportunities :
Advancements in Therapeutic Bronchoscope Systems is Creating Lucrative Bronchoscope Market Opportunities.
Therapeutic bronchoscope is an instrument which is used to treat various lung conditions. The advanced instruments are smaller and more flexible than previous models. This makes them easier to use and more comfortable for patients. They also have improved imaging capabilities, which allows doctors to see more detail of the airways. These systems are also compatible with endoscope systems that enhance the therapeutic activity and give access to distal airways.
For instance,
- In May 2024, Olympus introduced BF-1TH1100 therapeutic bronchoscope. It offers a 3.0mm working channel that provides a 29% increase in suction and the ability to pass a broad array of endo-therapy devices
Thus, advancement in therapeutic instruments is creating lucrative bronchoscope market opportunities in the coming years.
Top Key Players and Market Share Insights:
The Bronchoscope market is highly competitive with major players providing precise products to the national and international markets. Key players are adopting several strategies in research and development (R&D) and product innovation to hold a strong position in the global Bronchoscope market. Key players in the Bronchoscope industry include-
- Olympus Corporation. (Japan)
- Boston Scientific Corporation (United States)
- Cook (United States)
- Richard Wolf GmbH (Germany)
- Pentax Medical (Japan)
- KARL STORZ (Germany)
- Ambu A/S (Denmark)
- FUJIFILM Private Limited (Japan)
- Novatech Sa (France)
- Teleflex Incorporated (United States)
Bronchoscope Market Segmental Analysis :
By Type:
Based on type, the market is categorized as flexible and rigid.
Trends in the Type:
- There is a rise in adoption of flexible instruments for bronchoscopic lung volume reduction in COPD treatment.
- There is a rise in the trend for flexible instruments with AI-assisted navigation for real-time guidance.
The flexible segment accounted for the largest market share in 2024 and is expected to grow at the fastest CAGR over the forecast period.
- The flexible segment dominates the bronchoscope market trends.
- A flexible bronchoscope is a thin, flexible tube with a light and camera at the end. It is used to look inside the airways of the lungs.
- These instruments are easily moved into smaller airways.
- They are generally made of flexible material, such as silicone or plastic.
- Novel flexible bronchoscopes are introduced for bedside procedures in intensive care units and operating rooms to provide enhanced solutions.
- For instance, in August 2021, FDA approved Boston Scientific’s single-use bronchoscope. It is a flexible instrument that is available in three sizes. It provides high suction and imaging solutions for bronchoscopy procedures.
- Thus, the rise in the use of flexible instruments is influencing the segment at present and in the coming years.
By Application:
Based on application, the market is categorized into diagnosis and treatment.
Trends in application:
- There is a rise in the trend for single use bronchoscope for detection of infection risk.
- The integration of augmented reality and advanced navigation aids for proper diagnosis is improving the outcomes of the patients.
The diagnosis segment accounted for the largest market share in the year 2024.
- The diagnosis segment is further classified into lung cancer, pneumonia, chronic obstructive pulmonary disease (COPD), tuberculosis (TB), and others.
- Bronchoscopes are used in diagnosing various lung conditions.
- In lung cancer they allow for visual inspection of the airways. It allows the identification of tumors and the collection of tissue samples for biopsy.
- For pneumonia they are used to collect fluid or sputum samples for analysis. In COPD, the instrument helps assess the severity of the disease by visualizing the extent of airway damage and inflammation.
- In tuberculosis the instrument is used to collect sputum or bronchial washings for testing.
- Development of novel instruments offer enhanced diagnosis solutions for the above-mentioned conditions.
- For instance, in 2024, Olympus introduced a BF-H1100 diagnostic bronchoscope. It offers a large 2.2mm working channel, which provides an 11% increase in suction capability.
- Thus, the rise in the use of bronchoscope for diagnosis is influencing the segment growth.
The treatment segment is expected to grow at the fastest CAGR over the forecast period.
- The treatment segment is further categorized into foreign body removal, stent placement, ballon dilation, tumor removal, and others.
- Bronchoscopy is a safe and effective procedure that is used to treat a variety of lung conditions.
- They are used to effectively remove foreign objects that have been inhaled into the lungs, such as food, toys, or small objects.
- They are used to place stent in the airways to keep them open.
- Stents are small tubes that are inserted into the airway to help keep it open. They are generally made of metal, plastic, or silicone.
- Bronchoscopes are also used to dilate narrow airways and remove tumors from the airways.
- These treatment options provide minimally invasive alternatives to traditional surgery. They improve the recovery of the patients.
- Thus, these treatment options are supporting the growth of the segment.
By End User:
Based on end users, the market is categorized into hospitals & clinics, ambulatory surgical centers, diagnostic centers, and others.
Trends in the End User:
- There is a rise in the development of clinics that offer advanced diagnosis and therapeutic procedures specifically for lung conditions.
- The rise in the trend for same day procedure and discharge is influencing the adoption of ambulatory surgical centers.
The hospitals & clinics segment accounted for the largest bronchoscope market share of 54.13% in the year 2024.
- Hospitals are the dominant end-user in the bronchoscope industry. They provide well-equipped centers that perform various procedures for lungs.
- These medical facilities utilize these instruments for a wide range of diagnostic and therapeutic procedures related to the respiratory system.
- Hospitals have novel equipment to handle complex cases. They also have specialized departments for pulmonology and thoracic surgery.
- They invest in a variety of instruments, including flexible and rigid types, along with advanced imaging systems and accessories.
- Hospitals & Clinics are introducing robotic bronchoscopy solutions for various lung-related conditions.
- For instance, in 2024, New Robotic Bronchoscopy service is introduced at the Glenfield Hospital in the UK. This instrument enhances early diagnosis and treatment of lung cancer.
- Thus, these factors are influencing the growth of the segment.
The ambulatory surgical center segment is expected to grow at the fastest CAGR over the forecast period.
- Ambulatory surgical centers (ASCs) are the fastest growing segment of the market.
- This facility provides a cost-effective alternative to hospitals. They are beneficial for numerous minimally invasive procedures and the use of bronchoscopes.
- The facilities consist of advanced technology. They have experienced staff such as doctors and nurses among others.
- This allows them to perform a range of procedures safely and efficiently.
- These settings allow patients to get discharged the same day as the procedure.
- ASCs are a good option for patients who are healthy and who have a routine bronchoscopy procedure.
- This is beneficial for many patients as it saves time and money.
- Thus, as per the market analysis, these ambulatory surgical centers as end-user are developing the segment.
Bronchoscope Market Report Insights :
| Report Attributes | Report Details |
| Study Timeline | 2019-2032 |
| Market Size in 2032 | USD 2,756.28 Million |
| CAGR (2025-2032) | 7.5% |
| By Type |
|
| By Application |
|
| By End User |
|
| By Region |
|
| Key Players |
|
| North America | U.S. Canada Mexico |
| Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
| APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
| Middle East and Africa | GCC Turkey South Africa Rest of MEA |
| LATAM | Brazil Argentina Chile Rest of LATAM |
| Report Coverage |
|
Regional Analysis:
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2024, North America accounted for the highest market share at 40.69% and was valued at USD 630.29 Million and is expected to reach USD 1,032.20 Million in 2032. In North America, U.S. accounted for the highest market share of 72.91% during the base year of 2024.
The North America region dominates the market. This is because of the rise in the prevalence of respiratory conditions. These conditions include lung cancer, pneumonia, chronic obstructive pulmonary disease, tuberculosis, and others. These conditions are generally caused because of exposure to occupational hazards, and smoking. The diagnosis of conditions such as COPD is done using bronchoscope. The high prevalence of the condition further results in the use of bronchoscope.
For instance,
- The data by the Centers for Disease Control and Prevention, in 2023, states that COPD affected 6.4% individuals of the U.S. in 2011 and 6.5% in 2021. The prevalence has increased in adults greater than the age of 75.
Thus, as per the bronchoscope market analysis, the rise in the prevalence of respiratory conditions is driving the market in this region.
Asia Pacific is experiencing the fastest growth with a CAGR of 9.6% over the forecast period. The bronchoscope market trend across the region is attributed to factors such as the presence of major manufacturers and a strong emphasis on the advancements in bronchoscopes. These advancements enhance the effectiveness of the instruments. The advanced instruments offer enhanced images, flexibility, and maneuverability. They are known to develop diagnostic and therapeutic capabilities for respiratory conditions. Additionally, research activities for the development of robotic bronchoscopy system create potential opportunities for the launch of advanced instruments for various lung conditions.
The European region has an advanced healthcare infrastructure. The region has a high number of hospitals and clinics. They have a large number of skilled healthcare professionals. This makes it possible to provide high-quality bronchoscopy procedures to a wide number of patients. In addition, the European region has a strong regulatory framework for medical devices. This ensures that bronchoscopes sold in the region are safe and effective. Thus, as per the market analysis, the aforementioned factors are influencing the bronchoscope market demand in the coming years.
The Middle East and Africa (MEA) region is seeing a notable bronchoscope market demand characterized by significant potential. There is a growing awareness among healthcare professionals and the general population about the benefits of early diagnosis and treatment of respiratory conditions. This further fueling the demand for bronchoscopy procedures. Governments in the MEA region are highly investing in the healthcare industry. This leads to the demand for modern hospitals and clinics that are equipped with advanced medical technologies such as bronchoscopes. Thus, as per the analysis, these factors are influencing the demand of the market in this region
Latin America is an emerging region in the bronchoscope market share. This is because of the rise in ambulatory surgical centers (ASCs). ASCs are healthcare facilities that provide outpatient surgical care. They are a growing segment of the healthcare market, and they are increasingly being used for bronchoscopy procedures. These facilities are less expensive than hospitals, which is important in a region where healthcare costs are a concern. Thus, the rise in the use of ambulatory surgical centers creates potential for bronchoscope market growth.
Recent Industry Developments :
Product Launch:
- In May 2024, Olympus introduced a BF-H1100 diagnostic bronchoscope. It offers a large 2.2mm working channel, which provides an 11% increase in suction capability.
- In May 2024, Olympus introduced BF-1TH1100 therapeutic bronchoscope It offers a 3.0mm working channel that provides a 29% increase in suction and the ability to pass a broad array of endo-therapy devices
Key Questions Answered in the Report
How big is the Bronchoscope market? +
In 2024, the Bronchoscope market is USD 1,549.02 Million.
Which is the fastest-growing region in the Bronchoscope market? +
Asia Pacific is the fastest-growing region in the Bronchoscope market.
What specific segmentation details are covered in the Bronchoscope market? +
Type, Application and End User segmentation details are covered in the Bronchoscope market.
Who are the major players in the Bronchoscope market? +
Olympus Corporation. (Japan), Boston Scientific Corporation (United States), KARL STORZ (Germany) are some of the major players in the market.